7/105 sources · 3 publishersUpdated Oct 27, 21:21 UTC
Chemed Corp posts Q3 earnings beat with higher EPS and revenue
+1 new source since this summary was written
Chemed Corp reported third‑quarter 2026 results on Oct. 27. Adjusted diluted EPS came in at $6.75, topping the consensus estimate of $6.44. Revenue reached $690.9 million, up 10.6% year over year and above the $685.04 million forecast. VITAS Healthcare grew revenue 12.2% while Roto‑Rooter rose 7.5%, according to the company.
Why it matters
The earnings beat and revenue beat may reinforce the bullish outlook of analysts who have raised EPS forecasts in recent weeks. Investors will watch how the stronger hospice performance offsets the slower‑growing plumbing segment.
Key facts
- 1Adjusted diluted EPS was $6.75. tradingview.com
- 2Consensus EPS estimate was $6.44. investing.com
- 3Revenue was $690.9 million. tradingview.com
- 4Consensus revenue estimate was $685.04 million. investing.com
- 5Revenue grew 10.6% year over year. tradingview.com
- 6VITAS revenue grew 12.2% and Roto‑Rooter revenue grew 7.5%. tradingview.com
Summary written by AlphAI AI Desk from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.